Meredith E. Stewart

Meredith E. Stewart

Auto-generated profile, based on publicly available information

Meredith E. Stewart

Affiliation MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2021 in PLOS Biology
Verified
Journal Article
Open access
PDF file
SRSuzannah J. Rihn
Suzannah J. Rihn
AMAndres Merits
Andres Merits
SBSiddharth Bakshi
Siddharth Bakshi
MTMatthew L. Turnbull
Matthew L. Turnbull
AWArthur Wickenhagen
Arthur Wickenhagen
SMSuresh Mahalingam
Suresh Mahalingam
The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide pandemic causing substantial morbidity, mortality, and economic devastation. In response, many laboratories have redirected attention to SARS-CoV-2, meaning there is an urgent need for tools that can be used in laboratories unaccustomed to working with coronaviruses. Here we report a range of tools for SARS-CoV-2 research. First, we describe a facile single plasmid SARS-CoV-2 reverse genetics system that is simple to genetically manipulate and can be used to rescue infectious virus through transient transfection (without in vitro transcription or additional expression plasmids). The rescue system is accompanied by our panel of SARS-CoV-2 antibodies (against nearly every viral protein), SARS-CoV-2 clinical isolates, and SARS-CoV-2 permissive cell lines, which are all openly available to the scientific community. Using these tools, we demonstrate here that the controversial ORF10 protein is expressed in infected cells. Furthermore, we show that the promising repurposed antiviral activity of apilimod is dependent on TMPRSS2 expression. Altogether, our SARS-CoV-2 toolkit, which can be directly accessed via our website at https://mrcppu-covid.bio/, constitutes a resource with considerable potential to advance COVID-19 vaccine design, drug testing, and discovery science.

17 September 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ASAgnieszka M. Szemiel
Agnieszka M. Szemiel
AMAndres Merits
Andres Merits
Richard OrtonRichard Orton
Richard Orton
OMOscar MacLean
Oscar MacLean
Rute Maria PintoRute Maria Pinto
Rute Maria Pinto
MSMeredith E. Stewart
Meredith E. Stewart
Remdesivir (RDV), a broadly acting nucleoside analogue, is the only FDA approved small molecule antiviral for the treatment of COVID-19 patients. To date, there are no reports identifying SARS-CoV-2 RDV resistance in patients, animal models orin vitro. Here, we selected drug-resistant viral populations by serially passaging SARS-CoV-2in vitroin the presence of RDV. Using high throughput sequencing, we identified a single mutation in RNA-dependent RNA polymerase (NSP12) at a residue conserved among all coronaviruses in two independently evolved populations displaying decreased RDV sensitivity. Introduction of the NSP12 E802D mutation into our SARS-CoV-2 reverse genetics backbone confirmed its role in decreasing RDV sensitivityin vitro. Substitution of E802 did not affect viral replication or activity of an alternate nucleoside analogue (EIDD2801) but did affect virus fitness in a competition assay. Analysis of the globally circulating SARS-CoV-2 variants (>800,000 sequences) showed no evidence of widespread transmission of RDV-resistant mutants. Surprisingly, we observed an excess of substitutions in spike at corresponding sites identified in the emerging SARS-CoV-2 variants of concern (i.e., H69, E484, N501, H655) indicating that they can arisein vitroin the absence of immune selection. The identification and characterisation of a drug resistant signature within the SARS-CoV-2 genome has implications for clinical management and virus surveillance.

1 November 2015 in Journal of General Virology
Verified
Journal Article
Open access
MSMeredith Stewart
Meredith Stewart
AHAlexandra Hardy
Alexandra Hardy
GBGerald Barry
Gerald Barry
RPRute Maria Pinto
Rute Maria Pinto
Marco CaporaleMarco Caporale
Marco Caporale
MPMassimo Palmarini
Massimo Palmarini
Viruses have often evolved overlapping reading frames in order to maximize their coding capacity. Until recently, the segmented dsRNA genome of viruses of theOrbivirusgenus was thought to be monocistronic, but the identification of the bluetongue virus (BTV) NS4 protein changed this assumption. A small ORF in segment 10, overlapping the NS3 ORF in the +1 position, is maintained in more than 300 strains of the 27 different BTV serotypes and in more than 200 strains of the phylogenetically related African horse sickness virus (AHSV). In BTV, this ORF (named S10-ORF2 in this study) encodes a putative protein 50–59 residues in length and appears to be under strong positive selection. HA- or GFP-tagged versions of S10-ORF2 expressed from transfected plasmids localized within the nucleoli of transfected cells, unless a putative nucleolar localization signal was mutated. S10-ORF2 inhibited gene expression, but not RNA translation, in transient transfection reporter assays. In both mammalian and insect cells, BTV S10-ORF2 deletion mutants (BTV8ΔS10-ORF2) displayed similar replication kinetics to wt virus.In vivo, S10-ORF2 deletion mutants were pathogenic in mouse models of disease. Although further evidence is required for S10-ORF2 expression during infection, the data presented provide an initial characterization of this ORF.

1 November 2005 in Journal of General Virology
Verified
Journal Article
Closed access
BKBahman Khalesi
Bahman Khalesi
NBNicolai Bonne
Nicolai Bonne
MSMeredith Stewart
Meredith Stewart
MSMargaret Sharp
Margaret Sharp
SRSharanne Lee Raidal
Sharanne Lee Raidal
Psittacine beak and feather disease (PBFD) is recognized as a threat for endangered psittacine birds in Australia, New Zealand and South Africa. Several diagnostic methods for the detection of beak and feather disease virus (BFDV) infection have been developed but there are few studies comparing the relative merits or sensitivity and specificity of each diagnostic test. In this report, the results of PCR, haemagglutination (HA) and haemagglutination inhibition (HI) testing of diagnostic samples collected from 679 samples from a range of psittacine bird species suspected of being infected with BFDV are summarized and compared. There was a strong agreement (kappa = 0·757;P1 : 40 960) and four false-positive PCR results were detected in a batch of four feather samples. Of 143 birds that were feather PCR positive, only two had detectable HI antibody, and these birds were also feather HA negative, suggesting that they were developing immunity to recent infection. All birds with HI antibody were negative on feather HA testing. The assays confirmed BFDV infection in two endangered swift parrots (Lathamus discolor) and phylogenetic analysis of the sequence data generated from ORF V1 of these isolates provide further evidence of BFDV genotypes clustering in parallel with the Loriidae, Cacatuidae and Psittacidae.

1 April 2006 in Avian Pathology
Verified
Journal Article
Open access
MSMeredith E. Stewart
Meredith E. Stewart
RPRoss Perry
Ross Perry
SRSharanne Lee Raidal
Sharanne Lee Raidal
The complete genome of a novel Circovirus isolated from an Australian raven (Corvus coronoides) with feather lesions similar to those that occur in psittacine beak and feather disease is reported. Degenerate polymerase chain reaction primers were designed to amplify and sequence novel Circovirus DNA from affected feathers. Sequence analysis indicated that the tentatively named raven circovirus (RaCV) was 1898 nucleotides in size with two major open reading frames synonymous with other avian circoviruses, ORF C1 and ORF V1, likely to encode a putative capsid protein (Cap) and replicase-associated protein (Rep), respectively. In common with other circoviruses was the conservation of several nucleotide structures and amino acid motifs implicated in virus replication. Comparison with other members of the Circoviridae demonstrated that RaCV shares the greatest sequence homology with canary circovirus (CaCV) and pigeon circovirus (PiCV) and was more distantly related to the beak and feather disease virus, goose circovirus, duck circovirus and the two porcine circoviruses, PCV1 and PCV2. Phylogenetic analysis of the genome and the putative Cap and Rep proteins provided further evidence of the close relationship of RaCV with CaCV and PiCV. Identification d'un nouveau circovirus chez les corbeaux d'Australie (Corvus coronoides) avec une maladie des plumes Le génome complet d'un nouveau circovirus isolé d'un corbeau australien (Corvus coronoides) qui présentent des lésions des plumes similaires à celles observées dans la maladie du bec et des plumes des psittacidés est présenté. Les amorces dégénérées de la PCR ont été sélectionnées pour amplifier et séquencer l'ADN du nouveau circovirus à partir des plumes affectées. L'analyse de la séquence a montré que le circovirus, nommé provisoirement circovirus du corbeau (RaCV), avait 1898 nucléotides avec deux principaux cadres ouverts de lecture synonymes des autres circovirus aviaires, ORF C1 et ORF V1 qui respectivement étaient supposés coder une protéine de capside putative (Cap) et une protéine associée à la réplicase (Rep). La conservation de plusieurs structures nucléotidiques et de motifs d'acides aminés impliqués dans la réplication virale sont des caractéristiques communes avec les autres circovirus. La comparaison aux autres membres des Circoviridae a montré que le RaCV présentait la plus grande homologie de séquence avec le circovirus du canari (CaCV) et le circovirus du pigeon (PiCV) et était plus éloigné du virus de la maladie du bec et des plumes (BFDV), du circovirus de l'oie, du circovirus du canard et des deux circovirus porcins PCV1 et PCV2. L'analyse phylogénétique du génome, des protéines Rep et Cap putative ont fourni des preuves complémentaires de la relation étroite du RaV avec le CaCV et le PiCV. Identifizierung eines neuen Circovirus in australischen Krähen (Corvus coronoides) mit Befiederungsstörungen Es wird über das komplette Genom eines neuen Circovirus, das aus einer australischen Krähe (Corvus coronoides) mit Federveränderungen ähnlich denen bei der psittazinen Schnabel-und Federkrankheit (PBFD) isoliert worden ist, berichtet. Zur Amplifizierung und Sequenzierung der neuen Circovirus-DNS aus den betroffenen Federn wurden degenerierte PCR-Primer entwickelt. Die Sequenzanalyse zeigte, dass das vorläufig als Krähencircovirus (RaCV) bezeichnete Virus eine Größe von 1898 Nukleotiden hatte. Es wies wie bei den anderen aviären Circoviren zwei bedeutende offene Leserahmen auf, ORF C1 und ORF V1, die wahrscheinlich für das Kapsidprotein (Cap) bzw. für das Replikase assoziierte Protein kodieren. In Übereinstimmung mit anderen Circoviren war auch die Konservierung von mehreren Nukleotidstrukturen und Aminosäurenmustern, die mit der Virusvermehrung im Zusammenhang stehen. Der Vergleich mit anderen Mitgliedern der Familie der Circoviridae ließ erkennen, das das RaCV die größte Sequenzhomologie mit dem Kanariencircovirus (CaCV) und dem Taubencircovirus (PiCV) teilte und nur entferntere Beziehung zum BFDV, dem Gänse-, Enten- und zwei Schweinecircoviren (PCV1 unf PCV2) aufwies. Die phylogenetische Analyse des Genoms sowie der mutmaßlichen Cap- und Rep-Proteine erbrachten weitere Hinweise auf die enge Verwandtschaft des RaCV mit dem CaCV und PiCV. Identificación de un nuevo circovirus en cuervos Australianos (Corvus coronoides) con la enfermedad de la pluma Se describe el genoma completo de un nuevo Circovirus aislado a partir de cuervos Australianos (Corvus coronoides) con lesiones en las plumas similares a aquellas encontradas en la enfermedad del pico y las plumas de las psitácidas. Se diseñaron cebadores de PCR degenerados para amplificar y secuenciar el DNA del nuevo Circovirus a partir de las plumas afectadas. Los análisis de las secuencias indicaron que el circovirus llamado provisionalmente circovirus del cuervo (RaCV) tenía un tamaño de 1898 nucleótidos con dos marcos principales de lectura abierta al igual que otros circovirus aviares, ORF C1 y ORF V1, que probablemente codifiquen una supuesta proteína de la cápside (Cap) y una proteína asociada a la replicasa (Rep), respectivamente. La conservación de diversas estructuras nucleotídicas y motivos aminoacídicos implicados en la replicación vírica fueron comunes a otros circovirus. La comparación con otros miembros de Circoviridae demostró que RaCV compartía la mayor homología de secuencia con el circovirus del canario (CaCv) y el circovirus de la paloma (PiCV) y estaba relacionado de manera más distante con el virus de la enfermedad del pico y las plumas (BFDV), el circovirus del ganso, el circovirus del pato y los dos circovirus porcinos, PCV1 y PCV2. El análisis filogenético del genoma y de las supuestas proteínas Cap and rep proporcionaron más evidencias de la estrecha relación de RaCV con CaCv y PiCV.

1 March 2012 in Vaccine
Verified
Journal Article
Closed access
MSM. Stewart
M. Stewart
CDChrysostomos I. Dovas
Chrysostomos I. Dovas
ECE. Chatzinasiou
E. Chatzinasiou
TAT.N. Athmaram
T.N. Athmaram
MPM. Papanastassopoulou
M. Papanastassopoulou
Polly RoyPolly Roy
Polly Roy